Navigation Links
The Launch and Uptake of More Than 20 Novel Drugs Over The Next 10 Years Will Drive $12.5 Billion Growth in the Type 2 Diabetes Market
Date:5/20/2009

Commercial Potential of Market is Reflected in Burgeoning Pipeline of More than 400 Drugs in Development, According to a New Report from Decision Resources

WALTHAM, Mass., May 20 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the launch and uptake of more than 20 novel antidiabetic drugs over the next 10 years will drive the type 2 diabetes market to increase by $12.5 billion in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

The new Pharmacor report entitled Type 2 Diabetes finds that both novel and existing DPP-IV inhibitors and GLP-1 analogues - such as Merck's Januvia, Bristol-Myers Squibb/AstraZeneca's Onglyza and Amylin/Eli Lilly/Alkermes' Byetta LAR - hold the greatest promise for type 2 diabetes because these drug classes improve upon key areas of safety and efficacy. DPP-IV inhibitors have a very low risk of hypoglycemia and an excellent tolerability profile, making them suitable for widespread use. GLP-1 analogues, which combine superior glucose-lowering and weight loss capabilities compared with other drug classes, are particularly useful treatments for the significant proportion of type 2 diabetics who are obese.

"The commercial potential for drugs with demonstrated disease-modifying capabilities and long-term efficacy is reflected in the burgeoning pipeline for type 2 diabetes, which currently has more than 400 drugs in active development," said Decision Resources Analyst Christine Helliwell, Ph.D. "However, with a greater regulatory burden in the United States and an increasingly crowded market, the barriers for success are higher than ever before."

The report also finds that generic competition will weaken the market share of the PPAR-gamma agonists--Takeda's Actos and GlaxoSmithKline's Avandia--reducing sales of these agents by more than 50 percent over the 2008 to 2018 study period. The PPAR-gamma agonists, along with metformin (Bristol-Myers Squibb/Merck Sorono's Glucophage/Glucophage XR, Biovail/Depomed's Glumetza, Watson's Fortamet, generics) and the sulfonylureas, both of which are already generically available, are the most commonly prescribed first-, second-, and third-line oral therapies. Generic availability of all three drug classes will provide formidable competition for new, more-expensive drugs in the market.

About Decision Resources

Decision Resources (www.decisionresources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources, Inc. company.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at http://www.DecisionResourcesInc.com.

    Decision Resources               Decision Resources, Inc.
    Christopher Comfort              Elizabeth Marshall
    781-296-2597                     781-296-2563
    ccomfort@dresources.com          emarshall@dresources.com

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.


'/>"/>
SOURCE Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. American College of Physicians Chooses iPublishCentral to Launch its e-Book Strategy
2. USMLE Galaxy, LLC Launches Live and Cost Effective USMLE Review Courses and Practice Sessions Right on Your Desktop through its Subsidiary CcsWorkshop.com
3. Haverford Wellness Center Launches Web Site Devoted to Accurate Diagnosis and Proper Treatment to Cure Lyme Disease
4. American College of Physicians Chooses iPublishCentral to Launch its e-Book Strategy
5. Gold Star Resources Corp. Launches Humanitarian Society to Aid Liberian People
6. Photos: Will Ferrell Sunscreen to Launch Just in Time for Summer
7. Booty Camp(R) Potty Training Program as Featured in People Magazine is Launched on DVD
8. IBD Patient Launches iPhone Application to Help Doctors Treat Crohns and Ulcerative Colitis
9. Photos: USANA Launches National Rev3 Geocaching Challenge
10. ACORN CRO Launches STAR (Site Tracking and Recruitment)
11. StreetWise HSA(SM) Launched Nationally: First Low-Cost, Customizable Platform for Employee HSA Education
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... December 09, 2016 , ... The Justin Veatch Fund announced Thursday ... recommending the film Whispering Spirits and its discussion guide for use by ... education tool in the war against teen drug abuse. NCADD is the oldest ...
(Date:12/9/2016)... ... ... Mediaplanet today announces distribution of the latest edition of “Transplants,” a cross-platform ... an organ donor for the 123,000 people in the United States who are currently ... to 8 saves through organ donation and enhance many others through tissue donation, however ...
(Date:12/9/2016)... ... December 09, 2016 , ... "I had a terrible ... from Winchester, Va. "I thought that if the nebulizer had a more child-friendly design, ... fearing them." , He developed the patent-pending NEBY to avoid the need to deliver ...
(Date:12/8/2016)... ... December 08, 2016 , ... The Florida Hospital Tampa ... Hyperbaric Medical Society (UHMS), the leading authority in hyperbaric medicine. This accreditation identifies ... few hospitals and facilities have earned this distinction. This is the second time ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... to announce that “Natural Language Processing–Enabled and Conventional Data Capture Methods for Input ... JMIR Medical Informatics . , Results of the comparative usability study demonstrate that ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 8, 2016  Diplomat Pharmacy, Inc. (NYSE: DPLO) has been recognized ... Top Workplaces National Standard. To learn more about ... ... Inc.) ... survey administered by WorkplaceDynamics, LLC, a research firm specializing in organizational ...
(Date:12/8/2016)... -- Research and Markets has announced the addition of the ... ... report analyzes the worldwide markets for Endodontic Supplies in US$ Thousand. The report ... Japan , Europe , Asia-Pacific ... Annual estimates and forecasts are provided for the period 2015 through 2022. Also, ...
(Date:12/8/2016)... , Dec. 8, 2016   TriNetX ... Nationwide Children,s Hospital signed a membership ... accelerate the development of new cures. ... representing over 57 million patients globally, biopharmaceutical companies ... together to improve protocol design, site selection, patient ...
Breaking Medicine Technology: